FBCP Stock DD Founders Bancorp 08/06/2014 05:46:49

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
FBCP Founders Bancorp $FBCP Company Overview

Stock Message Board Recent Posts http://investorshangout.com/search?q=FBCP&...mp;yt0=Go!

Last Updated: 08/06/2014 05:46:45

Current Price and Quotes
Last Price 10.9499
Previous Close 10.85 Open 10.9499
Daily Range N/A - 10.9499 52wk Range 10.00 - 12.00
Volume 400 Dividend N/A
Average Vol (3m) 785 Yield N/A




Financials
Period Ending
Total Revenue
Cost of Revenue
Gross Profit
Operating Expenses

Research and Development
Sales, General and Admin.
Non-Recurring Items
Other
Operating Income
Income From Continuing Operations

Add'l Income/Expense Items
Earnings Before Interest and Tax
Interest Expense
Earnings Before Tax
Income Tax
Minority Interest
Equity Earnings Unconsolidated Subsidiary
Net Income Cont. Operations
Non Recurring Events

Discontinued Operations
Extraordinary Items
Effect of Accounting Changes
Other Items
Net Income
Preferred Stock and Other Adjustments
Net Income Applicable to Common Shareholders
Recent News

Jul 24, 2014 Flagstar to Present at 2014 KBW Community Bank Investor Conference
Jul 22, 2014 Flagstar Reports Second Quarter 2014 Results
Jul 8, 2014 Flagstar Announces Second Quarter 2014 Earnings Call
May 22, 2014 Flagstar To Present At 2014 KBW Mortgage Finance Conference
May 22, 2014 Flagstar To Audiocast Annual Meeting Of Stockholders



FBCP Founders Bancorp Research DD Guide

Stock Message Board http://investorshangout.com/search?q=FBCP&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/FBCP/quote
Stock Chart http://www.otcmarkets.com/stock/FBCP/chart
Company Info http://www.otcmarkets.com/stock/FBCP/company-info
Recent News http://www.otcmarkets.com/stock/FBCP/news
Financials http://www.otcmarkets.com/stock/FBCP/financials
Filings and Disclosure http://www.otcmarkets.com/stock/FBCP/filings
Short Sales http://www.otcmarkets.com/stock/FBCP/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/FBCP/insider-transactions
Research Reports http://www.otcmarkets.com/stock/FBCP/research
Summary http://finance.yahoo.com/q?s=FBCP
Historical Prices http://finance.yahoo.com/q/hp?s=FBCP+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=FBCP
Basic Chart http://finance.yahoo.com/q/bc?s=FBCP+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=FBCP+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=FBCP+Headlines
Press Releases http://finance.yahoo.com/q/p?s=FBCP+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=FBCP+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=FBCP+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=FBCP+Industry
Major Holders http://finance.yahoo.com/q/mh?s=FBCP+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=FBCP+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=FBCP+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=FBCP
Balance Sheet http://finance.yahoo.com/q/bs?s=FBCP
Cash Flow http://finance.yahoo.com/q/cf?s=FBCP+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/FBCP
Market Watch http://www.marketwatch.com/investing/stock/FBCP
Bloomberg http://www.bloomberg.com/quote/FBCP:US
Morningstar http://quotes.morningstar.com/stock/s?t=FBCP
Bussinessweek http://investing.businessweek.com/research/st...icker=FBCP
Barchart http://www.barchart.com/quotes/stocks/FBCP
OTC Short Report http://otcshortreport.com/index.php?index=FBCP
Investopedia http://www.investopedia.com/markets/stocks/FBCP/?wa=0
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 11

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 11

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 7

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 7

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 12

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 5

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 8

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 12

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 12

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding ADHD and the Role of RELEXXII in Treatment

Updated Category News Views 215

Supporting ADHD Awareness: The Role of RELEXXII This month marks a significant time for acknowledging and educating people about Attention Deficit Hyperactivity Disorder (ADHD). Alora Pharmaceuticals, the leading manufacturer behind RELEXXII® (methylphenidate hydrochloride extended-release tablet), is deeply committed to this cause. ADHD impacts various dimensions of...

Continue Reading
New Class Action Filed Against Paragon 28 Over Alleged Fraud

Updated Category News Views 111

Introduction to the New Class Action Against Paragon 28 Hagens Berman has recently taken action by filing a class action lawsuit against Paragon 28, Inc. (NYSE: FNA) alongside several of its senior executives. The case aims to hold the company accountable for alleged fraudulent activities affecting investors. Overview of the Allegations The lawsuit extends an ongoing...

Continue Reading
Subway Teams Up with ARC Raiders for Gaming Promo

Updated Category News Views 16

What’s Cooking Between Subway and Embark Studios? Subway’s diving headfirst into the gaming world, folks. It’s not a piece of cake to see a sandwich giant team up with a game studio, but today, Subway’s sidestepping the typical food deal. Instead, it's sharpening its digital claws with Embark Studios, a Stockholm-based game developer. They’re gearing up for the...

Continue Reading
CagriSema Breakthrough: Weight Loss Success in Adults

Updated Category News Views 312

Significant Weight Loss Achieved with CagriSema in Clinical Trial In recent findings, Novo Nordisk has unveiled compelling results from the extensive REDEFINE 1 trial, focusing on the innovative weight loss treatment, CagriSema. This clinical study assessed the efficacy of subcutaneous CagriSema—a fixed-dose combination of cagrilintide 2.4 mg and semaglutide 2.4 mg—in...

Continue Reading
Endor Labs Achieves Remarkable Growth in Application Security

Updated Category News Views 390

Endor Labs Shows Impressive Revenue Growth Endor Labs, a leader in application security, proudly announces a significant milestone: a whopping 225% year-over-year revenue growth. This achievement highlights the increasing demand for robust security measures that can keep pace with the rapid transformations in software development, especially given the rise of AI...

Continue Reading